|Year : 2014 | Volume
| Issue : 3 | Page : 159-162
99m Tc diethylenetriaminepentacetic acid angiotension-coverting enzyme inhibitor renography as screening test for renovascular hypertension in unilateral small kidney: A prospective study
Masood ul Hassan1, Shoukat H Khan1, Mohd Ashraf2, Saleem Najar3, Feroz Shaheen4
1 Department of Nuclear Medicine, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
2 Department of Radiation Oncology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
3 Department of Nephrology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
4 Department of Radiodiagnosis, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India
|Date of Web Publication||15-Nov-2014|
Masood ul Hassan
Department of Nuclear Medicine, Sher i Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir
| Abstract|| |
To know the probability of renal artery stenosis (RAS) in unilateral small kidney and function of the unilateral small kidney, which includes glomerular filtration rate, differential function, uptake, Tmax by 99m Tc diethylenetriaminepentacetic acid (DTPA) base and 99m Tc DTPA angiotensin converting enzyme (ACE) inhibition scan. All our patients were subjected to 99m Tc DTPA ACE inhibition renal scintigraphy. All the patients underwent either computed tomography (CT) angiography and magnetic resonance (MR) angiography was done in those patients in which kidney function test was deranged. Renal angiography was subsequently performed in cases with the suggestion of RAS on CT or MR angiography. The quantitative data was expressed as the arithmetic mean, standard deviation and percentages. The intergroup comparisons for parametric data were done by Student's t-test, whereas non-parametric data was compared with Mann-Whitney U-test. The intergroup comparisons were made by paired t-test and Wilcoxon sign rank test. P <0.05 was considered to be significant, and data was analyzed by Statistical package for social sciences(SPSS-20) software. Out of 47 patients, 25 patients were in the low probability group out of which none was positive for RAS on CT/MR angiography. Out of 47 patients, 12 were in the intermediate group out of which none was positive for RAS. Ten, out of 47 patients were suspected of high probability for RAS by ACE inhibition scan out of which 4 were positive for RAS by CT/MR angiography including one with bilateral RAS. 99m Tc DTPA angiotension-coverting enzyme inhibitor renography is a safe, non-invasive, sensitive, specific, and cost-effective test for excluding renovascular hypertension in patients who have normal or nearly normal renal function in unilateral small kidney.
Keywords: 99m Tc diethylenetriaminepentacetic acid angiotension-coverting enzyme inhibitor renography, probability of renal artery stenosis, unilateral small kidney
|How to cite this article:|
ul Hassan M, Khan SH, Ashraf M, Najar S, Shaheen F. 99m Tc diethylenetriaminepentacetic acid angiotension-coverting enzyme inhibitor renography as screening test for renovascular hypertension in unilateral small kidney: A prospective study. World J Nucl Med 2014;13:159-62
|How to cite this URL:|
ul Hassan M, Khan SH, Ashraf M, Najar S, Shaheen F. 99m Tc diethylenetriaminepentacetic acid angiotension-coverting enzyme inhibitor renography as screening test for renovascular hypertension in unilateral small kidney: A prospective study. World J Nucl Med [serial online] 2014 [cited 2020 Jul 7];13:159-62. Available from: http://www.wjnm.org/text.asp?2014/13/3/159/144815
| Introduction|| |
Renal vascular hypertension (RVH) accounts for <1% of cases of secondary hypertension in unselected populations, and is the cause of hypertension in as many as 30% of cases in selected populations.  RVH occurs when there is renal artery stenosis (RAS). In older patients, RAS usually is the result of atherosclerosis with increasing luminal narrowing. Fibromuscular dysplasia accounts for approximately 25% of all cases of RVH, and it affects children, young to middle-aged adults, and mostly women under the age of 35 years. 
Angiotension-coverting enzyme inhibitor (ACEI) renography is a safe, non-invasive, sensitive, specific, and cost-effective test for excluding renovascular hypertension in patients who have normal or nearly normal renal function. It can be performed in patients who have moderate to high-risk for renovascular hypertension; patients who have severe hypertension; or patients under the age of 30 years or over the age of 55 years who have abrupt or recent onset of hypertension; hypertension that is resistant to medical therapy; abdominal or flank bruits; unexplained azotemia; worsening renal function during therapy with ACEIs; end-organ damage; or occlusive disease in other vascular beds. 
Accordingly, the role of ACEI renography is to exclude RVH in hypertensive populations and more importantly, to identify patients who are candidates for surgery. The most widely accepted procedure for interpretation of ACEI renography is based on changes in renograms before and after angiotensin converting enzyme (ACE) inhibition.  In this qualitative grading system, an examination is considered as positive if grade decreases on the postcaptopril scan compared with the baseline study. According to a consensus report, ACEI renography can be categorized as low probability, intermediate probability, and high probability for RVH.  The sensitivity of the test varies from 83% to 100% and specificity ranges from 62% to 100%, respectively.  The prospective studies on RAS presenting as unilateral small kidneys are scanty. The present prospective study was undertaken to use renal scintigraphy as a screening test to diagnose RAS in patients presenting with unilateral small kidney.
| Materials and Methods|| |
The present study was conducted in the Department of Nuclear Medicine from July 2007 to April 2011. As per hospital policy, informed consent was taken and signed by the patients and referring doctors. The study included 47 patients with diagnosis of unilateral small kidney on ultrasound. All patients had clinical assessments - height, weight, pulse, and blood pressure (BP), laboratory investigations included serum urea, creatinine, uric acid, and urinalysis. All were subjected to baseline and 99m Tc diethylenetriaminepentacetic acid (DTPA) ACE inhibition renal scintigraphy All the patients underwent computed tomography (CT) angiography who had normal serum creatinine (<1.5 mg/dl) and magnetic resonance (MR) angiography was performed in those cases who had serum creatinine >1.5 mg/dl. Renal angiography was subsequently performed in cases with the suggestion of RAS on CT or MR angiography.
The probability for renovascular hypertension has been followed according to the consensus report on ACE inhibitor renography for detecting renovascular hypertension. 
Normal findings on ACEI renography indicate a low probability (<10%) for renovascular hypertension. Abnormal baseline findings that improve after ACE inhibition also indicate low probability for renovascular hypertension.
Patients with intermediate probability of disease have abnormal baseline findings, but the renogram is unchanged after ACE inhibition.
The probability is considered as high (>90%) when marked change of the renogram curve occurs after ACE inhibition compared with baseline findings. For DTPA, this change can be quantitated by measuring the change in relative function or absolute individual kidney function.
Specific interpretive criteria for DTPA 
Reduction in relative uptake >10% after ACEI administration indicates a high probability for renovascular hypertension; on an average, 5-9% indicates intermediate response. High probability is also associated with a 10% decrease in calculated glomerular filtration rate (GFR) of the ipsilateral kidney after ACEI administration. A small poorly functioning kidney (30% uptake) that shows no change after ACEI renography are indicative of intermediate probability for renovascular hypertension.
| Observation|| |
Out of the 10 cases in high probability group in 99m Tc DTPA ACEI scan, 4 (40.0%) were positive for RAS by CT/MR angiography.
All the four positive cases were confirmed by catheter renal angiography.
| Discussion|| |
Our study outlines the probability of RAS by 99m Tc DTPA ACEI scan for small kidney. Twenty-five out of 47 patients were in the low probability group out of which none was positive for RAS on CT/MR angiography. Out of 47 patients, 12 were in the intermediate group out of which none was positive for RAS. Ten out of 47 patients were suspected of high probability. Their differential function and change in GFR was more than 10% by ACE inhibition scan, out of which 4 were positive for RAS by CT/MR angiography including one with bilateral RAS. These four patients were further subjected to catheter renal angiography and were detected positive for RAS. Thus in high probability group sensitivity was 100% and specificity was 40%. Six (60%) patients in the high probability group showed a false-positive result. All the 6 patients were in the age ranges of 23-60 (mean = 46.3) years. The cause of this false-positivity is not clear, but could be explained on the basis of small renal arteries causing ischemia. However, only two of these six patients were hypertensive [Table 1] and [Table 2]. We did not study the renal vein renin levels in these patients, which could clarify if high renin levels are present in these patients with false-positive results.
|Table 2: Comparison of 99mTc DTPA base and 99mTc DTPA ACEI scan patients with high probability for renovascular hypertension and comparison with CT/MR angiography |
Click here to view
Taylor et al. gave the procedure guidelines for patients who are suspected of RAS and categorized them into low, intermediate and high probability.  In a meta-analysis of diagnostic tests for RAS in patients suspected of having renovascular hypertension using captopril-enhanced scintigraphy in 49 cases (30 males and 19 females) the sensitivity of captopril renal scntigraphy ranged from 58% to 95% and specificity ranged from 17% to 100%.  Roccatello and Picciotto found the sensitivity of 79.3% and specificity of 70%.  Abdulsamea et al. did a study on 74 children using 99m Tc MAG3 who had a clinical suspicion of renovascular disease, 12 out of 49 patients who had a low probability for RAS were proven to have RAS on digital subtraction angiography (DSA). Three out of 14 patients who were in the intermediate probability group had RAS on DSA. Nine out of 11 patients who were in high probability group had RAS on DSA.  Fernandez et al. evaluated 38 patients with renal failure (25 men, 13 women, age range: 29-83 years) by captopril scintigraphy retrospectively for the presence of RAS. Of nine patients with a high probability, six had unilateral artery stenosis with subsequent improvement of BP and improvement or stabilization of GFR after revascularization (angioplasty: n = 3, bypass: n = 1) or appropriate medical treatment (n = 2) and one patient had unilateral thrombosis with contralateral artery stenosis. In the last patient, percutaneous angioplasty showed slow GFR deterioration. Two false-positive scans showed unilateral change after captopril and were of a patient with a predialysis diabetic nephropathy and another patient with left kidney atrophy and no RAS on arteriography. Ten patients (26%) were classified as having intermediate probability of RAS. Two had RAS that was confirmed in one by subsequent improvement in BP and GFR stabilization after angioplasty and visualized by magnetic resonance imaging in the second patient. In the other eight patients, RAS was ruled out on arteriography in four. Among four other patients, MRI showed no stenosis in one patient, two patients underwent ultrasonography that had negative results and the fourth patient had negative DSA results. Finally, in 19 patients with a low probability of RAS on captopril scintigraphy, five had no RAS on arteriography. A total of 40 patients probably did not have a renovascular pathology. 
Dubovsky et al.  in their study have reported percentage values of false-positive results of as high as 60%. False-positive results have also been found in many other conditions like glomerular disease (especially with vasculitic etiology, in nephrosclerosis, in conditions of sodium depletion.  Moreover there are several other conditions, which can mimic or be associated with an activation of the rennin-angiotensin-aldosterone axis such as hypotensive effects of ACEI, heart failure, state of poor hydration and low urine flow, scleroderma, diabetic nephropathy, neurogenic bladder, and iatrogenic factors such as cyclosporine toxicity. 
| Conclusion|| |
99m Tc DTPA ACEI renography is a safe, non-invasive, sensitive and cost-effective screening test for excluding renovascular hypertension in patients who have normal or nearly normal renal function in unilateral small kidney. It is simple to perform, widely available, relatively inexpensive, and consensus criteria for its interpretation exists. Only those patients of unilateral small kidney who are in the high probability group should be subjected to renal angiography for confirmation of RAS.
| References|| |
|1.||Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sorlie P. The burden of adult hypertension in the United States 1999 to 2000: A rising tide. Hypertension 2004;44:398-404. |
|2.||Helin KH, Lepäntalo M, Edgren J, Liewendahl K, Tikkanen T, Tikkanen I. Predicting the outcome of invasive treatment of renal artery disease. J Intern Med 2000;247:105-10. |
|3.||He W, Fischman AJ. Nuclear imaging in the genitourinary tract: Recent advances and future directions. Radiol Clin North Am 2008;46:25-43, v. |
|4.||Nally JV Jr, Chen C, Fine E, Fommei E, Ghione S, Geyskes GG, et al. Diagnostic criteria of renovascular hypertension with captopril renography. A consensus statement. Am J Hypertens 1991;4:749S-52. |
|5.||Taylor A, Nally J, Aurell M, Blaufox D, Dondi M, Dubovsky E, et al. Consensus report on ACE inhibitor renography for detecting renovascular hypertension. Radionuclides in Nephrourology Group. Consensus Group on ACEI Renography. J Nucl Med 1996;37:1876-82. |
|6.||Prigent A, Taylor A. The role of ACE inhibitor renography in the diagnosis of renovascular hypertension. In: Henkin RE, Bova D, Karesh S, editors. Nuclear Medicine. Philadelphia: Elsevier Limited; 2006. p. 1051-75. |
|7.||Taylor AT Jr, Fletcher JW, Nally JV Jr, Blaufox MD, Dubovsky EV, Fine EJ, et al. Procedure guideline for diagnosis of renovascular hypertension. Society of Nuclear Medicine. J Nucl Med 1998;39:1297-302. |
|8.||Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: A meta-analysis. Ann Intern Med 2001;135:401-11. |
|9.||Roccatello D, Picciotto G. Captopril-enhanced scintigraphy using the method of the expected renogram: Improved detection of patients with renin-dependent hypertension due to functionally significant renal artery stenosis. Nephrol Dial Transplant 1997;12:2081-6. |
|10.||Abdulsamea S, Anderson P, Biassoni L, Brennan E, McLaren CA, Marks SD, et al. Pre- and postcaptopril renal scintigraphy as a screening test for renovascular hypertension in children. Pediatr Nephrol 2010;25:317-22. |
|11.||Fernandez P, Morel D, Jeandot R, Potaux L, Basse-Cathalinat B, Ducassou D. Value of captopril renal scintigraphy in hypertensive patients with renal failure. J Nucl Med 1999;40:412-7. |
|12.||Dubovsky EV, Russel CD, Japanwalla M. Bilateral response to captopril is nonspecific. Eur J Nucl Med 1992;8:575. |
|13.||Roccatello D, Picciotto G, Rabbia C, Pozzato M, De Filippi PG, Piccoli G. Prospective study on captopril renography in hypertensive patients. Am J Nephrol 1992;12:406-11. |
[Table 1], [Table 2]